ARCHIVES

FDA Official Outlines agency’s Views On Efficacy Requirement

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

Rauscher Labels With Congress, Says NCI Needs More Money

May 2, 1975

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

April 6, 2007

UT System (Again) Directs DePinho to Cure MD Anderson Faculty Angst

November 7, 2014

NCI Plans $61 Million For Six-Year Program In Biomarker Research For Early Detection

December 4, 1998

Schmidt Already Working For NIH Despite His Opposition To Kennedy’s New Research Panel

April 5, 1974

Clinical Trials: NCI Forms Panel To Help Implement Recommendations

December 12, 1997